Predictions
Mediclin AG
Start price
Target price
Perf. (%)
€3.32
07.03.22
07.03.22
-
07.03.23
07.03.23
0.60%
19.03.22
19.03.22
EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
Vivoryon Therapeutics N.V.
Start price
Target price
Perf. (%)
€19.50
06.01.22
06.01.22
-
06.01.23
06.01.23
-45.13%
13.03.22
13.03.22
Medigene AG
Start price
Target price
Perf. (%)
€3.90
02.07.21
02.07.21
-
02.07.22
02.07.22
-20.90%
09.03.22
09.03.22
Innovative
Dependend from some customers or products
Higher risks for its business
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€61.80
08.03.21
08.03.21
-
08.03.22
08.03.22
-21.91%
09.03.22
09.03.22
Drägerwerk AG & Co. KGaA ST
Start price
Target price
Perf. (%)
€61.80
08.03.21
08.03.21
-
08.03.22
08.03.22
-26.29%
09.03.22
09.03.22
MorphoSys AG
Start price
Target price
Perf. (%)
€82.98
08.03.21
08.03.21
-
08.03.22
08.03.22
-72.98%
09.03.22
09.03.22
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Good rating
Standard Investments for future growth
Fresenius Medical Care AG & Co KGaA ST
Start price
Target price
Perf. (%)
€57.94
01.03.21
01.03.21
-
01.03.22
01.03.22
-2.93%
02.03.22
02.03.22
MorphoSys AG
Start price
Target price
Perf. (%)
€33.45
05.12.21
05.12.21
€40.00
05.12.22
05.12.22
-27.32%
01.03.22
01.03.22
Could be worthwhile Investment >10% per year
Medigene AG
Start price
Target price
Perf. (%)
€3.71
22.02.22
22.02.22
€5.00
22.02.23
22.02.23
18.89%
23.02.22
23.02.22
Could be very worthwhile Investment >20% year
Very capable Management
Good culture
Little innovation
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€8.98
21.02.21
21.02.21
€10.00
21.02.22
21.02.22
-54.90%
22.02.22
22.02.22
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Known brand
Very Future proof/growth oriented business model
Vita 34 AG
Start price
Target price
Perf. (%)
€15.55
21.02.21
21.02.21
-
21.02.22
21.02.22
-25.08%
22.02.22
22.02.22
Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
Formycon AG
Start price
Target price
Perf. (%)
€67.40
07.02.21
07.02.21
€80.00
07.02.22
07.02.22
-20.03%
08.02.22
08.02.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High valuation
Low dividend yield expected
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€36.24
01.02.21
01.02.21
€40.00
01.02.22
01.02.22
1.56%
01.02.22
01.02.22
MPH Health Care AG
Start price
Target price
Perf. (%)
€26.00
16.05.21
16.05.21
€40.00
16.05.22
16.05.22
-5.77%
29.01.22
29.01.22
Could be very worthwhile Investment >20% year
Undervalued
Future proof or reliable business model
Significant cyclical dependencies